Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.

Authors

Pavlos Msaouel
Andrew L Hong
Elizabeth A Mullen
Michael B Atkins
Cheryl Lyn Walker
Chung-Han Lee
Marcus A Carden
Giannicola Genovese
W Marston Linehan
Priya Rao
Maria J Merino
Howard Grodman
Jeffrey S Dome, George Washington University
Conrad V Fernandez
James I Geller
Andrea B Apolo
Najat C Daw
H Courtney Hodges
Marva Moxey-Mims
Darmood Wei
Donald P Bottaro
Michael Staehler
Jose A Karam
W Kimryn Rathmell
Nizar M Tannir

Document Type

Journal Article

Publication Date

9-12-2018

Journal

Clin Genitourin Cancer

DOI

10.1016/j.clgc.2018.09.005

Comments

epub ahead of print

APA Citation

Msaouel, P., Hong, A., Mullen, E., Atkins, M., Walker, C., Lee, C., Carden, M., Genovese, G., Linehan, W., Rao, P., Merino, M., Grodman, H., Dome, J., Fernandez, C., Geller, J., Apolo, A., Daw, N., Hodges, H., Moxey-Mims, M., Wei, D., Bottaro, D., Staehler, M., Karam, J., Rathmell, W., & Tannir, N. (2018). Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.. Clin Genitourin Cancer, (). http://dx.doi.org/10.1016/j.clgc.2018.09.005

Peer Reviewed

1